期刊文献+

临床药师参与抗凝治疗会诊的药学实践与分析 被引量:1

Pharmaceutical practice and analysis of clinical pharmacists participating in anticoagulant therapy consultation
下载PDF
导出
摘要 目的探讨临床药师在抗凝治疗会诊中促进合理用药的作用。方法选取4例有代表性的疑难少见会诊病例,重点分析利伐沙班在低蛋白血症患者应用的出血风险,使用华法林的妊娠女性抗凝治疗的调整及监护,颅内静脉血栓、左心耳血栓患者使用直接口服抗凝药(DOACs)的决策。结果临床药师协助临床医生制定个体化抗凝治疗方案并提供药学服务,患者转归良好。结论临床药师参与抗凝治疗会诊对抗凝药物的合理使用具有重要作用。 Objective To explore the role of clinical pharmacists in promoting rational drug use in anticoagulant therapy consultations.Methods Four representative cases of difficult and rare consultation were selected to analyze the bleeding risk of rivaroxaban in patients with hypoproteinemia,the adjustment and monitoring of anticoagulant therapy in pregnant women using warfarin,and the strategy of patients using DOACs for cerebral venous thrombosis and left atrial appendage thrombosis.Results Clinical pharmacists assisted clinicians in formulating individualized anticoagulation treatment programs and provided pharmaceutical care,and the patients recovered well.Conclusion The participation of clinical pharmacists in the consultation of anticoagulant therapy plays an important role in the rational use of anticoagulant drugs.
作者 张丹 李黎 周楠 赵颖 曹璐 张鹏 Zhang Dan;Li Li;Zhou Nan;Zhao Ying;Cao Lu;Zhang Peng(Department of Pharmacy,Shaanxi Provincial People′s Hospital,Xi′an 710068,China)
出处 《实用药物与临床》 CAS 2023年第3期228-232,共5页 Practical Pharmacy and Clinical Remedies
关键词 抗凝治疗会诊 临床药师 低蛋白血症 妊娠 颅内静脉血栓 左心耳血栓 Anticoagulant therapy consultation Clinical pharmacist Hypoproteinemia Pregnancy Cerebral venous thrombosis Left atrial appendage thrombus
  • 相关文献

参考文献4

二级参考文献35

  • 1Hall JG, Pauli RM, Wilson K. Maternal and fetal sequelae of anticoagulant during pregnancy. Am J Med, 1980, 68(1): 122-140.
  • 2Stevenson RE, Burton M, Ferlauto GJ, et al. Hazards of oral anticoagulants during pregnancy, lAMA, 1980, 243(15): 1549-1551.
  • 3Wesseling J, Van Driel D, Heymans HS, et al. Coumarins during pregnancy: long-term effects on growth and development of schoolage children. Thrornb Haemost, 2001, 85(4): 609-613.
  • 4Bonnar J. Hemostasis and coagulation disorders in pregnancy. In: Bloom AL, Thomas DP, editors. Haemostasis and Thrombosis. London: Churchill Livingstone, 1994: 570-583.
  • 5Suri V, Keepanasseril A, Aqqarwal N, et al. Mechanical valve prosthesis and anticoagulation regimens in pregnancy: a tertiary centre experience. Eur I Obstet Gynecol Reprod Biol, 2011,159(2): 320-323.
  • 6Jeejeebhoy FM. Prosthetic heart valves and management during pregnancy. Can Faro Physician, 2009, 55(2): 155-157.
  • 7Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med, 2000, 160(2): 191-196.
  • 8McLintock C. Anticoagulation therapy in pregnant women with mechanical prosthetic heart valves: no easy option. Thromb Res, 2011, 127 Suppl 3:S56-S60.
  • 9Kawamata K, Neki R, Yamanaka K, et al. Risk and pregnancy outcome in women with prosthetic mechanical heart valve replacement. Circ J, 2007, 71(2): 211-213.
  • 10Van Driel D, Wesseling J, Rosendaal FR, et al. Growth until puberty after in utero exposure to coumarins. Am J Genet, 2000, 95(5): 438443.

共引文献177

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部